Article in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Khouloud AyedLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0001-6033-8597
Amal GorrabLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Hichem BouguerraLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Rym AkroutLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0003-0020-3775
Sami ZekriConfocal Microscopy Unit, Faculty of Medicine of Tunis, University Tunis El Manar, Tunis 1007, Tunisia.ORCID 0000-0003-0079-5061
Wassim Y AlmawiFaculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Rahma BoughribaLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.
Khalil ChoukriLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0003-3534-8237
Dhouha BachaService d'Anatomie Pathologique, Hôpital Mongi Slim, La Marsa 2046, Tunisia.ORCID 0000-0002-8430-0072
Alessandra PaganoEquipe 9 Cytosquelette et Neurophysiopathologie, Faculté Pharmacie site Timone, UMR7051 Institut de Neuro Physiopathologie (INP), 27 Bd Jean-Moulin, 13005 Marseille, France.
Jean-François LouetAdipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine, Department of Molecular and Cellular Biology, Côte d'Azur University Inserm, 06204 Nice, France.ORCID 0000-0002-1626-7098
Hervé KovacicEquipe 9 Cytosquelette et Neurophysiopathologie, Faculté Pharmacie site Timone, UMR7051 Institut de Neuro Physiopathologie (INP), 27 Bd Jean-Moulin, 13005 Marseille, France.ORCID 0000-0001-6509-4210
Mounia Tannour-LouetAdipo-Cible Research Study Group, Mediterranean Center of Molecular Medicine, Department of Molecular and Cellular Biology, Côte d'Azur University Inserm, 06204 Nice, France.ORCID 0000-0003-0614-063X
Asma GatiLaboratory of Genetics, Immunology, and Human Pathologies, Department of Biology, Faculty of Sciences of Tunis, University Tunis El Manar, Tunis 2092, Tunisia.ORCID 0000-0001-8507-0451
Funding
INSERM NonePHC-Utique 13G0819The Institut National Du Cancer INCa 2018-1-PL BIO-05The Tunisian Ministry of Higher Education and Scientific Research None
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Leptin Drives Breast Cancer Aggressiveness Acting Through the Activation of the NCOA1/STAT3 Pathway. · full record | OpenQuestion